Female Urinary Retention

Female Urinary Retention - StatPearls - NCBI Bookshelf 03/11/23, 9:25 AM
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.
Female Urinary Retention

Stephen W. Leslie; Prashanth Rawla; Joseph M. Dougherty.
Author Information and Affiliations

Last Update: May 30, 2023.
Continuing Education Activity

Urinary retention, or the inability to voluntarily void urine, is one of the most prevalent
presenting urologic complaints in the emergency department. Typically, it is diagnosed when
there is a high post-void residual volume. Post-Void residual volume measurements are usually
done using ultrasound and provide an estimate of the amount of urine remaining in the bladder
after urination. Two of the most common causes of chronic urinary retention in women are
bladder muscle dysfunction and obstruction. The condition is important as it can lead to
significant clinical problems if left untreated, such as bladder decompensation, hydronephrosis,
renal failure, vesicoureteral reflux, nephrolithiasis, and urinary tract infections, as well as
symptoms including suprapubic pain, feelings of incomplete emptying, weak urinary stream,
urgency, and incontinence. This activity reviews the evaluation and management of urinary
retention in women. It highlights the role of the interprofessional team in collaborating to provide
well-coordinated care and enhance outcomes for affected patients.
Objectives:
Identify the causes of urinary retention in females.
Review risk factors for urinary retention in females.
Describe treatment options for urinary retention in females.
Explain the importance of improving coordination amongst the interprofessional team to

enhance care for females affected by urinary retention.
Access free multiple choice questions on this topic.
Introduction
Urinary retention is one of the most prevalent urological complaints resulting in patients
presenting to the emergency department, although this is typically in men rather than women. It
is loosely defined as the inability to pass urine, but a more precise definition is a bit
challenging. The best consensus-recommended definition is a complete inability to void
spontaneously or persistently elevated post-void residual urine volumes, which would lead to an
adverse clinical outcome without any intervention.[1]
Typically, the diagnosis is made from the finding of a high post-void residual urine volume, often
along with symptoms of suprapubic pain or inability to void. Post-void residual urine volume
measurements are typically made by using a bladder scanner or ultrasound to estimate the
amount of urine remaining in the bladder after urination or by straight catheterization. Patients
with acute retention will typically complain of suprapubic pain and inability to void normally,
but some patients, particularly the elderly, may be asymptomatic.[2] The normal maximum
bladder capacity is about 500 mL, so any amount over this is clearly abnormal and suggestive of
https://www.ncbi.nlm.nih.gov/books/NBK538497/ Page 1 of 26
urinary retention.
The condition is vital as it can lead to significant clinical problems if left untreated, such as
bladder decompensation, hydronephrosis, renal failure, vesicoureteral reflux, nephrolithiasis, and
urinary tract infections, as well as symptoms including suprapubic pain, feelings of incomplete
emptying, weak urinary stream, urgency, and incontinence.[3]
Etiology
Female urinary retention is either acute or chronic and can be categorized according to the
International Continence Society as:
Complete (full retention) or partial (high post-void residuals)
Acute or chronic
Symptomatic or asymptomatic
Mechanism (obstructive or non-obstructive)
Bladder pressure: high or low
Female urinary retention is caused by one of four general etiologies: neurological, obstructive,
pharmacological, and psychogenic.
A number of etiologies exist for this condition.[4][5][6][7][8][9] Common specific causes

include:
Acute vulvovaginitis
Anesthesia (general or regional)
Bladder neck stenosis
Bladder radiation
Brain tumor, infection, trauma, or stroke
Cauda equina syndrome
Cerebral palsy
Cervical cancer
Constipation
Cystocele
Cystotomy not recognized during surgery
Detrusor sphincter dyssynergia
Diabetes
Fibroids
Fowler's syndrome
Frailty
Genital herpes
Heavy metal poisoning
Iatrogenic nerve injury during pelvic surgery
Joint replacement surgery
Meatal stenosis
Meningomyelocele
Multiple sclerosis
Neurologic injury during surgery
Obstruction from a vaginal hematoma, packing, sling procedures, urethral foreign body,
urinary calculi, pelvic organ prolapse, failure of pelvic floor relaxation, etc.
Older age
Parkinson disease
Pelvic injury, trauma, or malignancy
Pelvic organ prolapse
Pessary: poorly fitting or out of position
Pharmacological from long-term use of antihistamines, anticholinergics, overactive

bladder medications, opioids, tricyclic antidepressants, antispasmodics, antipsychotics,
SSRIs, alpha-adrenergic agonists, etc.
Polypharmacy
Rectocele
Spina bifida
Spinal cord injury or infection
Surgery, especially incontinence procedures such as pubovaginal slings
Urethral cancer
Urethral diverticula or thrombosed caruncle
Urethral injury or scarring
Urethral swelling from infection
Vaginal childbirth; especially if instruments were required
Vaginal lichen planus
Aging affects detrusor contraction strength, bladder sensation, and urinary flow rate.[8][10]
[11] As these age-related changes progress, post-void residual urine volumes increase, and the
risk of urinary retention rises. The mechanisms of these changes include an increased ratio of
collagen to muscle in the detrusor, a gradual reduction in bladder sensation over time, and a
diminishing recognition by the brain of bladder filling.[12][13][14] Interestingly, post-void
residual volumes are generally unchanged without other pathology.[11]
Bladder outlet obstruction in women can be caused by pubovaginal sling surgery or pelvic
organ prolapse.[15][16] These disorders cause pinching or kinking of the urethra resulting in
impaired bladder emptying. External compression of the urethra can also cause similar problems
with bladder function. Extrinsic urethral compression is most often the result of constipation,
fibroids, tumor mass, or sling surgery. Some fibroids and pelvic tumors may place direct pressure
on the pelvic nerves and cause radiculopathy.[17] Urethral cancer can cause incomplete bladder
emptying; it is extremely rare.[18]
While constipation is clearly a cause of incomplete bladder emptying in children, its role in
adults is less clear except for fecal impactions. Urethral lesions such as strictures, diverticula, and
caruncles can also cause a bladder outlet obstruction. Strictures are usually the result of
infections or prior urological procedures such as urethral dilations. It is estimated that urethral
strictures may occur in 4% to 13% of women with urinary retention due to bladder outlet
obstruction.[19]
Detrusor underactivity is defined as a contraction of reduced strength and/or duration, which

results in a failure to empty the bladder adequately within a reasonable period. It generally
requires urodynamic testing to make a confirmed diagnosis. The most common causes include
pelvic neuropathy, central nervous system disorders, bladder muscle dysfunction, aging,
neurological diseases, and medication effects.
Diabetic women are far more likely to have higher post-void residual urine volumes than non-
diabetic females due to both motor and sensory neurogenic changes, as more than fifty percent of
women with longstanding diabetes will develop peripheral neuropathy.[20][21] Thirty percent of
diabetic women will demonstrate detrusor interactivity, and thirteen percent will have a
completely atonic bladder.[22] The specific mechanism is that prolonged hyperglycemia induces
increased oxidative stress with high cytokine release inside peripheral nerve cells while also
interfering with capillary blood flow to the neurons, causing mild ischemia.[23] The result is
peripheral neuropathy which often affects bladder function and can result in urinary retention.
Fowler's syndrome is a rare clinical problem that causes urinary retention in young women.
First described in 1988, the syndrome usually occurs after menarche in the 2nd to 3rd decades,
and there is often a triggering event such as a surgical procedure or an acute illness.[24]
[25] Before the onset of urinary retention, most patients with Fowler's syndrome have minimal
voiding issues, such as an intermittent stream or infrequent micturition.[26]
Fowler's syndrome should be suspected in all younger women with non-neurogenic, non-
obstructive urinary retention unrelated to surgery, trauma, or childbirth.[25] It is frequently
associated with polycystic ovary syndrome (40%) and opioid use.[27][28] It is thought that
hormonal changes associated with polycystic ovary syndrome result in relaxation failure of the
female urethral sphincter muscle, causing an overactive, non-relaxing sphincter.[29] This
increases urethral afferent activity, which inhibits bladder afferent signaling to the brain resulting
in poor bladder sensation and markedly decreased detrusor contractility.[28] These effects
potentiate the bladder storage spinal reflex and result in dysfunctional voiding, high residual
volumes, and urinary retention. The yearly incidence is reported as 0.2 cases per 100,000
population.[30] Other neurological causes of urinary retention in younger women include
multiple sclerosis and spinal cord injury or compression.[29][31]
Fowler's syndrome is characterized by the following characteristics:[25][28]
Younger women in 2nd and 3rd decades of life
Not associated with pelvic surgery or childbirth
There may have a triggering event such as a surgical procedure or an acute illness
Often associated with polycystic ovary syndrome (in 40% of cases) and opioid use
Urinary retention or high post-void residual urine volumes, typically at least 1,000 mL at
some point
Increased bladder capacity
Decreased bladder sensation
Markedly reduced bladder contractions and detrusor voiding pressures
High urethral sphincter closing pressure and muscle tone (usually detectable by urethral
sphincter EMG)
Increased sphincteric volume on transvaginal ultrasound
Intermittent catheterization is often painful, especially on withdrawal of the catheter
Functional bladder outlet obstruction would involve any abnormal contraction or failure of
relaxation of the urethral sphincter during voiding. This would include detrusor sphincter
dyssynergia, dysfunctional voiding, Fowler's syndrome, or primary bladder neck obstruction.
Dysfunctional voiding is defined as a variable, intermittent, or fluctuating urinary flow rate in
neurologically intact individuals due to involuntary spasmodic contractions of the urethral
sphincter. Unlike detrusor sphincter dyssynergia, there is no underlying neurogenic disorder.
Detrusor sphincter dyssynergia is caused by the contraction of the urethral sphincter and/or the
periurethral striated muscles during bladder emptying. It is due to a disruption of the neural
connections between the pontine micturition center and the caudal spinal cord. The specific
diagnosis usually requires urodynamics with electromyography and/or video urodynamics.
Epidemiology
Urinary retention is rare in women and much more common in men due to benign prostatic
hyperplasia (BPH). There are an estimated 3 to 7 cases per 100,000 women yearly, and the
female-to-male ratio is 1 to 13.[8][32] Compare this with men, where about one-third of all
males over age 80 will develop acute urinary retention.[33] In older women, it may be
asymptomatic.[2] Up to one-third of older women will have incomplete bladder emptying with
increased post-void residual volumes.[34] It is generally accepted that female urinary retention is
grossly underestimated and underdiagnosed.[35]
Female urinary retention is also common after pelvic reconstructive surgeries and incontinence
procedures. Preoperative voiding dysfunction and higher post-void residual volumes increased
the risk for postoperative urinary retention.[36]
Urinary retention is relatively common after a normal vaginal delivery, with 14% of women
found to develop urinary difficulty immediately postpartum, typically recognized as not voiding
by 6 hours after delivery.[37] This increases to 20.6% in women who underwent an instrumented
delivery, presumably from stretching the perineal muscles and possible denervation injury.[38]
[39] An episiotomy increases the chances of postpartum urinary retention.[39] Long-term
voiding dysfunction may be present in up to 5% of postpartum patients with urinary retention,
especially if their initial residual urine volumes are >1,000 mL.[40]
Postoperative urinary retention after a cesarean section with epidural anesthesia will occur in
about 25% of patients. Hysterectomy is also associated with postoperative urinary retention,
which can be reduced by nerve-sparing techniques or otherwise minimizing pelvic dissection,
which appears to cause some degree of recoverable denervation.[41][42][43]
An unrecognized cystotomy as a complication of gynecologic surgery can also cause female

urinary retention. The inadvertent cystotomy rate is reportedly about 1% to 3% after
hysterectomy and 2% to 5% after retropubic sling surgery.[44][45][46][47][48]
Pathophysiology
Voluntary urination requires close coordination between muscles of the pelvic floor, bladder, and
urethra, as well as the nerves innervating them. Any disruption along the pathway can cause
urinary retention. Even if this pathway coordinates and works properly, mechanical obstruction
can cause urinary retention or interfere with bladder emptying. Obstruction can result from the
urethral channel's narrowing, extrinsic compression, or significantly increased sphincter muscle
tone. Neurological impairment can result in incomplete relaxation of the urinary sphincter,
inefficient or deficient detrusor muscle contraction, spinal cord infarction/demyelination,
epidural abscess, epidural metastasis, Guillain-Barre syndrome, neuropathy, stroke, or trauma to
the spinal cord.[49][50]
Trauma to the lower genitourinary tract, pelvis, or urethra can also cause obstruction. Bladder
outlet obstruction in women may also result from constipation, pelvic organ prolapse, pelvic
masses, diverticular stones, hematomas, or kidney stones. A urinary tract infection can cause
swelling or inflammation of the urethral mucosa resulting in a restricted lumen and subsequent
urinary retention.[49][50][51][52]
An unrecognized cystotomy during gynecologic surgery can initially appear as voiding

dysfunction. Often, patients will present with postoperative urinary retention or only void in
small amounts. Symptoms may be non-specific such as abdominal fullness or hematuria, while
delayed findings include ileus, peritonitis, genitourinary fistula, and sepsis. This is because the
cystotomy opening acts as a one-way valve that lets urine out of the bladder into the low-
pressure peritoneal but does not permit drainage back into the bladder.
History and Physical

History and physical should focus on any history of urinary retention and symptoms involving
the lower genitourinary tract. The symptoms can be discomfort with urination, hematuria,
urethral discharge, foul-smelling urine, urgency, a feeling of incomplete emptying, or lower
abdominal pain. Discomfort and lower abdominal pain are more likely to be associated with
acute retention, while chronic retention may be asymptomatic or have more subtle symptoms
such as a general feeling of a reduced urge to void, a sensation of incomplete emptying, a slow or
intermittent urinary stream (unusual in females), stranguria, or hesitancy. Patients with urinary
retention may also present with overflow incontinence which is present in <1% of women
presenting lower urinary tract symptoms.[53]
The patient should be asked about previous trauma, surgeries, or radiation to the pelvic and
genitourinary area. A history of back pain, fever, IV drug use, or other neurological symptoms
could point to possible causes of urinary retention. All medications, including OTC, prescription,
and herbal, should be reviewed to determine whether side effects of these could be causing or
exacerbating urinary retention.[54][55] Anticholinergics, antihistamines, and alpha-adrenergic
agonists, such as common decongestants, can all tend to facilitate urinary retention.
The physical exam should include at least a lower abdominal palpation and a focused
neurological examination. A rectal and pelvic exam should also be performed. On palpation of
the lower abdomen, there may be some discomfort, or the bladder may be palpable. On the rectal
exam, note any masses, fecal impaction, perineal sensation, and sphincter tone. The pelvic
examination will detect atrophic vaginitis, tumors, urethral diverticula, prolapse, cystoceles, and
rectoceles. A focused neurological exam may reveal deficits that may suggest a neurogenic
etiology.[56][57][58]
An attempt should be made to identify potentially curable causes of female urinary retention
such as a retained or ill-fitting pessary, urinary tract infection, pelvic organ prolapse, urethral
diverticula with a stone, fibroids, mesh erosion from prior pelvic surgery, etc.
A post-void residual urine volume should be obtained, preferably within 10 to 15 minutes of

voiding, and a urinalysis should be done.
Evaluation
From a clinical standpoint, female urinary retention is divided into acute/postoperative and
chronic.
Acute female urinary retention will typically present immediately after a precipitating event
such as trauma, childbirth, botulinum toxin detrusor injections for overactivity, or surgery in a
patient who previously had no urinary issues. Symptoms are usually significant lower abdominal
pain, inability to void, a strong urge to urinate, and lower abdominal or suprapubic swelling.
Urodynamics testing with pressure-flow studies is not generally necessary or recommended for
patients with acute urinary retention unless prolonged or intractable, but it may be helpful in
cases of chronic retention or in patients with prior incontinence procedures to help identify an
obstructed urethra.
Numerous risk factors for acute and postoperative female urinary retention exist.[59][60][61]
[62] These include:
Age over 50 years
Administration of anticholinergic drugs during a surgical procedure
Creation of a cystotomy possibly unrecognized during GYN surgery
Diabetes
Duration of anesthesia of more than 2 hours
Higher IV fluid administration while under an anesthetic (>750 mL)
Hypertension
Joint replacement surgery
Neurological disease or injury
Pharmacological effects (anticholinergic, alpha agonists, etc.)
Pelvic trauma
Preexisting voiding dysfunction or high post-void residual urine volumes
Previous episodes of urinary retention
Prior pelvic or incontinence surgery
Regional anesthesia (23% vs. 17% with a general anesthetic)
Surgery: radical hysterectomy - 20% rate of postop acute urinary retention
Surgery: low anterior resection - 68% rate of postop acute urinary retention
Chronic female urinary retention generally has milder but more varied symptoms such as
dysfunctional voiding, slow or intermittent urinary stream, hesitancy, straining, or incontinence
from overflow. There is usually no abdominal or suprapubic pain and typically no immediate
precipitating event. Symptoms have usually been present for an extended time, or patients may
even be asymptomatic, with the urinary retention discovered only incidentally. Interestingly, a
sensation of incomplete bladder emptying is not a reliable indicator of a high post-void residual
volume.[63]
The American Urological Association has defined chronic urinary retention as "an elevated post-
void residual (PVR) urine volume of greater than 300 mL that persisted for at least six months
documented on two or more separate occasions."[3] The main risks for patients with chronic
urinary retention are persistent bacteriuria, recurrent UTIs, permanent bladder muscle damage,
nephrolithiasis, and renal damage. The risk for renal disease is increased in the presence of
persistently elevated bladder storage pressure, although the majority of neurologically intact
women with chronic urinary retention will have detrusor underactivity and low pressures.
Risk factors for high-risk chronic urinary retention include:[3]
Bladder stones
Hydronephrosis
Hydroureter
Recurrent or symptomatic UTIs
Renal failure (GFR of <60 mL/min)
Urinary incontinence associated with perineal skin changes or sacral decubitus ulcers
Urosepsis
A urinalysis and culture are necessary for all female patients with urinary retention. This urine
may have to be obtained via catheterization if the patient is unable to void voluntarily. The
diagnosis of urinary retention is commonly made via obtaining a post-void residual urine
volume. If the patient can void on her own, a bladder scan is utilized after the patient urinates to
evaluate the amount of urine still in the bladder. More than 300 mL of urine in the bladder after
voiding suggests urinary retention, although most clinicians use 200 mL as the maximal,
acceptable post-void volume.[64][65][66]
If the patient is unable to urinate, catheter placement may be necessary. If more than 400 mL of
urine passes after catheterization in the first 15 minutes, this suggests urinary retention, and the
catheter should remain in place unless the patient is willing and able to perform clean
intermittent self-catheterization at regular intervals. Between volumes of 200 mL and 400 mL,
the catheter may be removed immediately or left in place, depending on the clinical scenario.
Under 200 mL, the catheter can generally be removed, and urinary retention is unlikely.[33][67]
[68]
Urodynamic testing is extremely helpful in differentiating detrusor underactivity from bladder

outlet obstruction in women with chronic, unexplained urinary retention. With detrusor
underactivity, detrusor pressure will be reduced or possibly even absent.[69] Urinary flow may
be absent, intermittent, low, or possibly even normal.[69] Valsalva-assisted voiding (from
straining and increased abdominal pressure) will typically cause an intermittent urinary flow and
can be identified with urodynamics findings of an increased flow coinciding with an increase in
abdominal pressure.
Bladder outlet obstruction in women is far less common than in men. Typically, this disorder
demonstrates elevated detrusor pressure with either prolonged voiding time and/or a reduced
urinary flow rate.[70][71][72] Video-urodynamics (pressure flow studies with fluoroscopy) is the
current standard for diagnosing bladder outlet obstruction in women.[73]
Pressure-flow studies should be evaluated cautiously as women typically have much lower
normal voluntary voiding pressures than men, and the correlation between urinary retention
severity and pressure-flow results is somewhat inconsistent.[74][73] Additional findings might
include detrusor sphincter dyssynergia (a neurological disorder), non-relaxation of the urethral
sphincter (as in Fowler's syndrome), or primary bladder neck obstruction. Video urodynamics
can be very helpful in these more complex cases.[75][76] Patients who demonstrate sustained
high detrusor storage pressure, especially with decreased bladder compliance or uncorrected
stage 3 or 4 pelvic organ prolapse, are at increased risk of renal damage and should be monitored
by renal ultrasonography and serum creatinine/GFR.
Cystoscopy can sometimes help detect anatomical disorders that may be contributing to urinary
retention, such as strictures, masses, stones, or urethral erosions from surgical material used in
prior pelvic surgeries.
Evaluation Summary:
Acute urinary retention usually immediately follows a precipitating event such as surgery,
botulinum toxin detrusor injections, injury, or childbirth.
Immediate symptoms of suprapubic pain, inability to void, urgency, and incomplete

bladder emptying are typical of acute retention.
Retention is more likely after regional anesthetic blocks, older patients, diabetics, use of
anticholinergics, and a history of prior pelvic surgeries.
Post-void residual urine volumes will be >200 mL in patients with urinary retention.
Postoperatively, patients should be closely monitored for bladder function and residual.
Postoperative patients with residuals over 400 mL should be given an opportunity to void
and catheterized if they fail.
Immediate treatment is urethral catheterization, either with a Foley or intermittent self-

catheterization.
All patients with acute postoperative urinary retention should have their catheter irrigated.
An inability to extract the injected fluid suggests a possible unrecognized cystotomy, and a
cystogram should be performed.
Continuous Foley drainage is suggested for volumes >1,500 mL, at least for a short time.
If the urinary voiding disorder lasts >6 months, it is chronic retention.
Urodynamics and video urodynamics are not necessary for acute retention but may be
helpful in chronic patients.
Cystoscopy can be helpful in chronic retention to identify obstructive causes that are
potentially treatable.
Patients with prior pelvic surgeries can develop pelvic organ prolapse or mesh erosions.
Treatment / Management
The initial management of a patient diagnosed with urinary retention is usually a urethral Foley
catheter. The amount drained immediately should be recorded. Patients with more than 1,500 mL
drained immediately from the bladder after catheter insertion are at risk for postobstructive
diuresis.[77] Those with pre-existing renal failure (azotemia), bilateral hydronephrosis, or
congestive heart failure are at an even higher risk of developing the disorder.
Postobstructive diuresis is a pathological condition of uncontrolled salt and water excretion. It

is defined as more than 200 mL of urinary output per hour for at least 2 hours or more than 3,000
mL of urine over 24 hours.[77] Urinary output and serum electrolytes should be monitored for
patients at risk. In severe cases or where patients cannot drink freely, intravenous fluids of
normal saline at no more than 75% of the prior hour's urinary output should be administered, and
serum electrolytes should be checked regularly.[77] Urinary specific gravity can be used as a
simple marker to monitor the disorder's progress. A urine specific gravity of 1.010 would be iso-
osmolar to normal serum and generally indicates the resolution of the postobstructive diuresis if
it reaches 1.020 or more.[77] The process usually resolves in most cases in 24 hours. (See our
companion reference StatPearls article on Postobstructive Diuresis.)[77]
In patients who are totally unable to void or have very large residuals (1,500 mL or more), a
Foley catheter is preferred initially for monitoring due to possible postobstructive diuresis as
well as therapeutic bladder decompression and recovery. If, for any reason, a urethral catheter
cannot be inserted, a suprapubic tube can be placed instead.
Bladder overdistension injury will occur if an overdistended bladder (defined as 120% or more
of normal capacity or generally more than 600 mL) is maintained for 24 hours or longer.[78]
[79] Bladder wall ischemia can begin in as little as 30 minutes after the onset of detrusor
overdistension. The ischemia results from stretched and narrowed blood vessels which reduce
blood flow along with the markedly increased intravesical pressure. Smooth muscle contractility
is further reduced due to direct detrusor muscle fiber injury and increased intracellular calcium.
[80] The process is largely reversed after Foley catheter placement, but reperfusion can release
oxidative free radicals and inflammatory chemicals such as tumor necrosis factor-alpha, which
can cause further direct bladder tissue injury.[79][81] The larger the volume and the longer the
urinary retention is unrecognized, the greater the potential for permanent detrusor muscle
deterioration into acontractile fibrous tissue.[82]
Acute urinary retention is best managed with a short-term Foley catheter or clean intermittent
patient self-catheterization until the resolution of the disorder. An initial Foley catheter is usually
preferred if residual volumes of >1,000 mL are encountered. This can be converted to a self-
catheterization program if the patient is willing and able to do so. A benefit of self-
catheterization is that when normal bladder function returns, the post-void residual volumes will
decrease, and it will become obvious that the catheterizations are no longer needed. For this
reason, it is suggested that the patient measure and record the post-void residual amount
occasionally, such as once a day. Another advantage is that if the patient ever feels a return of
symptoms, she can perform a self-catheterization and avoid a visit to the emergency department.
The risk of a significant decrease in renal function or permanent bladder damage is minimal in
acute urinary retention if identified and treated promptly. A Foley catheter, suprapubic tube, or
clean intermittent self-catheterization will be necessary for female patients with acute urinary
retention not due to a mechanical obstruction who remain unable to void adequately on their
own. A full recovery is unlikely if it has not occurred by six to eight months after the original
acute event, which now becomes chronic urinary retention.
Intermittent self-catheterization is preferred over indwelling catheters or suprapubic tubes

whenever possible, except in cases of very large initial bladder volumes of 1,500 mL or more
where an initial period of continuous Foley catheterization is suggested.[83][84] Patients with
acute retention following a major abdominal or pelvic trauma with a possible urethral injury
should initially receive a suprapubic tube.[85][86]
Patients suspected of a possible unrecognized surgical cystotomy (essentially all female patients
with urinary retention immediately after any major pelvic surgery) can be checked by simple
irrigation of the bladder through a Foley catheter with 100 mL of sterile saline. In patients with
an unrecognized cystotomy, the fluid can be instilled but cannot be withdrawn. In such cases, an
immediate x-ray cystogram should be done. Small extraperitoneal bladder perforations can often
be managed conservatively with just a Foley catheter, but if the leak is particularly large or
intraperitoneal, an immediate surgical repair is required.[87][88]
Clean Intermittent Self-Catheterization
Patients who are candidates for clean intermittent self-catheterization need to have the manual
dexterity and strength to perform the procedure, as well as the mental ability to understand the
procedure and the willingness to do so on an ongoing, regular basis. For many patients, an initial
schedule might be four times a day: morning, after lunch, after dinner, and at bedtime. Additional
catheterizations are permitted depending on the volumes obtained and patient sensation. Some
patients may need to perform self-catheterization six times a day and possibly once at night as
well.
The patient should always void first, if able. The timing of the catheterizations should be
adjusted to maintain a catheterized urinary volume of no more than 500 mL. When the
catheterizations are consistently less than 200 mL, consideration can be given to performing
them less often or stopping the procedure altogether.
Learning how to perform self-catheterization can be challenging for many women. They may not
be familiar with the anatomy, or their body habitus may make it difficult. The use of a mirror is
suggested and can be helpful for many women who otherwise would have difficulty doing the
procedure. A flashlight is also helpful. Patients should wash their hands or use gloves (non-
sterile) before performing self-catheterization. Pre-lubricated, non-touch catheters are
commercially available. Washing the genital area and using an antiseptic wipe just before
catheterizing is recommended to minimize urinary tract infections. Prophylactic antibiotics are
not generally used except in exceptional cases.
An experienced female nurse is suggested for this training to minimize patient anxiety and
discomfort. This should not be rushed, and patients should be given ample opportunity to learn
and practice the technique if they are capable and interested. The importance of maintaining a
regular schedule of bladder emptying should be emphasized to avoid urological complications.
Many educational aids and videos are available online and from various healthcare organizations
and societies, including the Society of Urologic Nurses and Associates (SUNA) and the
American Urological Association (AUA).
Voiding Trial
At some point, patients with acute retention requiring a Foley will be ready for a voiding trial.
(This is not necessary for patients doing self-catheterization as their residual urine volumes will
indicate when it's safe to discontinue the practice.) For most neurologically intact patients, this
can be done within a few days to a few weeks after the initial episode of urinary retention. If the
original bladder volume drained was over 1,500 to 2,000 mL, a longer period is recommended to
allow the bladder muscle more time to recover, such as two to four weeks.
For an active voiding trial, such as can be done in an office or clinic, the bladder is filled with
300 mL of sterile saline or to maximum tolerable capacity. The catheter is then removed, and the
patient is allowed to void. Success is generally defined as a post-void residual volume of 100 mL
or less, although less than 200 mL may be acceptable in some cases. Success may also be defined
as a post-void residual volume of no more than one-third of the amount instilled.
A spontaneous voiding trial may be easier for hospitalized patients who can just have their
catheters removed early in the morning (such as at 5 or 6 AM before the usual change of nursing
shifts) and then be taken to the bathroom to try voiding after 4 hours. A bladder scan should be
done for a post-void residual when the patient voids, but the scan should be done even if the
patient is unable to urinate in order to avoid bladder overdistension. The patient is then given
another opportunity to void every 2 hours until they are successful or their residual volumes
approach 500 mL. Success is again defined as post-void residual urine of 100 mL or less. It may
also be defined as a post-void residual of only one-third or less of the total bladder volume.
A post-void residual of over 200 mL is regarded as abnormal, while a reading of 100 to 200 mL
is considered equivocal.[65][89] Whether a urinary catheter remains in place is determined by
the clinical scenario (acute or chronic, high risk or low) and the patient's risk status, preferences,
home situation, comorbidities, and abilities.
Chronic urinary retention is treated initially the same as acute urinary retention: either with a
urethral Foley catheter, suprapubic tube or by clean intermittent self-catheterization. AUA
Guidelines also recommend a renal function test (serum creatinine) and renal ultrasound as initial
baseline tests in newly diagnosed patients with chronic urinary retention.[3] An initial period
with a continuously draining catheter is suggested in patients with significant medical
comorbidities, UTI, sepsis, large urinary volumes drained immediately after catheterization
(typically >1,500 mL), or who are otherwise at high risk for postobstructive diuresis or other
complications. This can be converted into a self-catheterization program as soon as practicable in
appropriate patients.
Long-term intermittent self-catheterization is a reasonable treatment option for many women

with chronic urinary retention, as most will demonstrate detrusor underactivity and low bladder
storage pressures, which minimizes the risk of renal failure.[90] Those patients with complete
urinary retention will require a catheter in some form for bladder drainage.
Patients with acute or chronic retention associated with a urinary tract infection, sepsis,
hemodynamic instability, a high likelihood of severe postobstructive diuresis, acute myelopathy,
or acute renal failure should generally be admitted.[33][91]
Conservative treatment measures have had some limited success in treating female urinary
retention. Physical therapy with biofeedback has shown benefits in some patients with prolapse,
rectoceles, cystoceles, and dysfunctional voiding.[92]
Those patients with specific obstructive disorders usually benefit from customized therapy.
Patients with pelvic organ prolapse clearly benefit from treatment of the prolapse.
Using a pessary to correct stage 3 or 4 pelvic organ prolapse resulted in improved post-
void residual volumes in 75% of such patients with urinary retention.[93]
Surgical prolapse repair resulted in normal post-void residual volumes of 89%.[94]
Urethral dilations are not generally recommended in female patients with urinary retention,
especially not after synthetic sling surgery, due to the risk of mesh erosions, but may be of
use in selected cases with known urethral strictures.[95][96][97]
Most urinary retention patients with urethral erosions from prior pelvic incontinence
surgery will see a relief of their voiding problem by the removal of the transvaginal sling
and urethral reconstruction.[98][99]
In carefully selected female patients with primary bladder neck obstruction, about 85%
saw relief of their urinary retention from surgical transurethral bladder neck incision.[100]
[101] However, since this procedure can cause permanent incontinence, its use in female
patients is not yet generally recommended.
Botulinum toxin injections have been used successfully in men with primary bladder neck
obstruction, but there is inadequate data available about its use in female patients with
chronic urinary retention.
Bethanechol is a cholinergic agonist that can increase detrusor muscle tone. However, it
has not demonstrated any significant benefit, either alone or with prostaglandin E2, in
treating non-obstructive female urinary retention even with detrusor underactivity and is
therefore not recommended.[102][103][104] Bethanechol also has significant potential
side effects.
Alpha-adrenergic blocker medications such as tamsulosin generally appear to help, but many
studies regarding its use are small, lack a control group, are short-term, and results are somewhat
inconsistent. Overall, alpha-adrenergic blocker medications are generally recommended as most
available studies show the benefit of this therapy in female patients with urinary retention. The
medication is well tolerated, and no other simple, more effective alternative treatment exists.
[105][106][107][108][109][110] Tamsulosin therapy pre-operatively has also been shown to help
reduce postoperative female urinary retention.[91][111]
Sacral neuromodulation is a minimally invasive treatment that utilizes an implantable device to

provide gentle electrical stimulation of the S3 nerve root to modulate bladder function. While
particularly effective for many patients with intractable overactive bladder disorders, sacral
neuromodulation also offers an overall 70% success rate in treating non-obstructive female
urinary retention.[27][35][112][113][114][115]
The mechanism of action is not well understood but is thought to be through inhibition of the
guarding reflex, which normally prevents accidental urinary leakage by activating somatic
efferent fibers to contract the external urinary sphincter. This is initiated by afferent signals to
Onuf's nucleus during periods of increased pressure, such as during a cough.[113] It is effective
in patients with detrusor underactivity and can be used in older patients, although it is more
effective in younger women.[8][115]
Many ladies are unhappy about the generally accepted treatments of alpha-blockers, urethral
dilation, intermittent catheterization, permanent catheterization, pessary placement, surgery,
Botulinum toxin urethral injections, pelvic floor exercises, and physical therapy due to
inconvenience, discomfort, or lack of efficacy which makes sacral neuromodulation a viable
alternative for many.[116] Sacral neuromodulation is a reasonable and effective treatment for
urinary retention due to detrusor sphincter dyssynergia and Fowler's syndrome.[117]
Sacral neuromodulation is relatively costly, and long-term efficacy is uncertain. A surgical

procedure is needed for placement. Battery life is limited, and older models will require periodic
implant replacement or at least periodic recharging for newer, rechargeable units.[118] The tined
leads can migrate or break, the device may need periodic reprogramming or cease functioning,
and the entire device may break down over time.[8] The reported overall removal rate for sacral
neuromodulation after implantation is 10% to 20%.[114][119][120][121] (See our companion
article on Sacral Neuromodulation.)[113]
Fowler syndrome may be best treated by sacral neuromodulation as it has been shown to
increase detrusor contractility without increasing urethral activity.[116] Suprapubic tubes are
uncomfortable in younger ladies, and intermittent self-catheterization is often painful in this
disorder due to excessive urethral muscle pressure. In one study of 26 women with Fowler's
syndrome and urinary retention treated with sacral neuromodulation for 72 months, an
impressive 77% could void independently without needing catheterization.[112]
Sacral neuromodulation is the recommended treatment for Fowler's syndrome, as surgeries and
medications are not usually effective, and there is evidence of restoration of normal voiding in
many patients.[112] Voltages of <3 volts have been found to provide better results.
[122] Botulinum toxin injection into the urethral sphincter has not yet been adequately tested in
patients with this disorder, but 37% to 43% of patients in small test groups indicated
improvement.[29][123][124][125] Ultimately, patients who fail these measures may require a
continent urinary diversion for relief.[29]
Percutaneous tibial nerve stimulation is similar to sacral neuromodulation because the

intention is to activate the S3 nerve route. This is achieved indirectly by stimulating the tibial
nerve at the ankle. This avoids surgical implantation of tined leads or stimulator battery packs
but is generally less effective. Patients receive tibial nerve stimulation treatments weekly in the
office or clinic for 12 weeks.
There is limited data on the use of percutaneous tibial nerve stimulation for female urinary
retention, although a recent systematic analysis showed a moderate success rate of 25% to 41%,
with more than half the patients indicating subjective improvement.[126] Overall, percutaneous
tibial nerve therapy is considered roughly half as effective as direct S3 root stimulation with
sacral neuromodulation. The FDA has approved a new implantable tibial nerve stimulator, and
another is currently under investigation. There is no data on the efficacy of these implantable
devices for female urinary retention as they were approved for detrusor overactivity.
Treatment Summary:
Initial treatment for acute or chronic urinary retention is the same; Foley catheter,
suprapubic tube, or self-catheterization depending on patient capability and willingness.
Short-term continuous catheterization is recommended for high-risk patients and those

with larger bladder residual volumes (>1,500 mL).
Intermittent self-catheterization is recommended whenever possible.
Persistent post-void residuals of <200 mL generally indicate resolution of urinary

retention.
Acute retention for six months or more is treated as chronic urinary retention.
Retention caused by specific obstructive disorders should have those problems corrected.
Pelvic organ prolapse can be treated with a pessary or surgery.
Urethral strictures can be treated with dilation, which is otherwise not recommended,
particularly not after sling surgery due to the high risk of urethral erosions.
Botulinum toxin and transurethral incision or resection may be helpful in selected patients,
but there is a worrisome risk of permanent incontinence.
Bethanechol is not recommended due to its low efficacy and high side effect profile.
Alpha-adrenergic blockers such as tamsulosin are generally recommended as the

preponderance of the available evidence suggests a benefit.[111]
Sacral neuromodulation and percutaneous tibial nerve stimulation are recommended

options in non-obstructive chronic female urinary retention.
Differential Diagnosis
Causes of urinary retention and conditions that may mimic it include but are not limited to
obstruction at any point along the lower genitourinary tract or nerve dysfunction. A blockage
may result from pelvic masses, constipation, urethral stone, infection-causing urethral
inflammation, stenosis, strictures, urethral diverticulum, and neurological dysfunction.[127]
Prognosis
The prognosis of urinary retention is fair if recognized early and treated promptly. Acute urinary
retention, such as immediately after major surgery, will usually resolve by itself within a few
days to weeks. Obstructive causes may not resolve without surgical relief of the obstruction.
Immediate issues of bladder overdistension and upper tract deterioration can be managed by
either continuous or intermittent catheterization. Resolution of chronic urinary retention is more
problematic and depends on the underlying cause, comorbidities, and availability of therapies
such as sacral neuromodulation.
In a double-blinded, prospective study of 600 patients, predictive nursing and early drinking
water therapy have been shown to reduce the incidence of postpartum urinary retention.[128]
Sacral neuromodulation and percutaneous tibial nerve stimulation are still probably underutilized
therapies for chronic female urinary retention. Implantable tibial nerve stimulators may prove to
be an important future therapeutic option but require further testing to demonstrate efficacy for
female urinary retention.
Intraurethral valve pumps, which are short silicone urethral catheters that contain an internal
valve and pump mechanism that is activated by the patient using a remote control, are FDA
approved, available, and reasonably effective in selected cases but tend to be costly,
uncomfortable, and prone to leaking although future generations of these devices may overcome
these limitations.[129][130][131] They have been used mostly outside the US for 20 years and
are tolerable for about half of the patients who have tried them.[130]
Follow-up
The American Urological Association Guidelines recommend a yearly follow-up examination

including a history and physical, and post-void residual determinations are considered minimal.
High-risk patients, including those previously diagnosed with renal failure, nephrolithiasis, or
hydronephrosis, should also have yearly kidney function studies (creatinine) and renal
ultrasonography.[3]
Complications
Complications of urinary retention include but are not limited to acute kidney injury, bladder
injury, and urinary tract infections. There are also complications with catheterization, both
suprapubic and urethral, such as urinary tract infections, urethral erosion, bladder spasms,
bladder stones, reflux nephropathy, cellulitis at the cystostomy site, nephrolithiasis, renal
parenchyma damage, renal deterioration, etc.[5][33][132][133] Urethral catheterization can result
in a direct urethral injury during insertion. Suprapubic catheterization can result in trauma to the
bladder/colon and develop leaks or an overlying skin infection.[91][134]
Another important complication seen in clinical practice is post-obstructive diuresis. This

phenomenon is characterized by the excretion of large amounts of salt and water immediately
after the urinary is relieved by a catheter. It may be a normal physiological response to the
obstruction, but physicians should keep a close eye on patients as some continue to excrete large
amounts of urine and are at risk for dehydration and metabolic abnormalities.[135] Risk factors
include patients with azotemia, fluid retention, and those with particularly high bladder volumes,
typically 1,500 or more.[77]
Transurethral resection or incisions have demonstrated some efficacy, but there is a considerable
risk of permanent urinary incontinence. Botulinum toxin urethral injections are a promising
treatment method, but there is no standardized methodology or dosage at this point and only
limited data on efficacy. Sacran neuromodulation has proven efficacy but requires surgical
implantation and routine follow-up and has a high re-operation and explanation rate.
Postoperative and Rehabilitation Care

A standardized protocol for monitoring female patients after childbirth, prolonged anesthesia,
and major pelvic surgeries is highly recommended as it can help identify individuals with acute
urinary retention before there is extensive detrusor damage. A bladder ultrasound to check
residual volume at 4 to 6 hours post-op has been suggested as a minimal, reasonable protocol.
With the wide availability of bladder ultrasound equipment in recovery rooms and hospitals, a
bladder residual can easily be checked, especially in higher-risk individuals.
Rehab centers should emphasize the teaching and reinforcement of intermittent self-
catheterization techniques for female patients with urinary retention. They should also be able to
customize a schedule based on each patient's individual clinical situation, bladder capacity,
comorbidities, capabilities, and urine production.
Deterrence and Patient Education

Urinary retention is the inability to pass urine and can be acute or chronic. Although uncommon
in women compared to men, it can still lead to significant issues of permanent bladder damage,
renal deterioration, stones, infections, and Foley catheter dependency when not recognized and
treated early. Patients should speak with their doctors if they have any issues with urination, such
as dribbling of urine intermittently, a foul smell of urine, a feeling of incomplete emptying,
hesitancy, etc. Checking a post-void residual urine volume with either a straight catheterization
or ultrasound can quickly establish or eliminate a diagnosis of urinary retention.
Pearls and Other Issues
Acute and chronic female urinary retention are initially treated the same.
Always convert to self-catheterization, if possible, until the patient is voiding normally.
Use an experienced female nurse for self-catheterization patient teaching.
Urodynamics is not generally very helpful in evaluating patients with acute urinary
retention.
Tamsulosin is worth trying as there is evidence of some efficacy; it is well tolerated and
may provide a psychological (placebo effect) benefit.[111]
All younger ladies with unexplained urinary retention should be suspected of Fowler
syndrome.
All postoperative patients with urinary retention should have their catheters irrigated. A
cystogram should be performed if no irrigation can be aspirated from the bladder.
Sacral neuromodulation and/or posterior tibial nerve stimulation are reasonable treatment
options for most women with chronic urinary retention.
Patients who demonstrate very little detrusor activity and lack bladder sensation tended to
have the worst outcomes after aggressive management (transurethral surgery, botulinum
toxin urethral injections) of their urinary retention.[136]
After significant pelvic trauma with a suspected urethral injury, a suprapubic tube should
be placed.
In rare cases, an imperforate hymen can cause an obstructive type of urinary retention in
pubescent girls.[137]
Enhancing Healthcare Team Outcomes

Diagnosis and treatment of urinary retention require an interprofessional team effort. Primary
care physicians, emergency department physicians, and hospitalists should be able to recognize
the early signs and symptoms of urinary retention. Nurses should monitor the urine output in
hospitalized patients and report to physicians if they notice a decrease or complete absence of
urine output or voiding. Protocols for post-partum voiding have demonstrated usefulness in
minimizing urinary complications such as acute retention but require close cooperation between
OB-GYN, urology, family practice, and nursing. Urology should be involved in unusual,
difficult, or refractory cases.
Nursing must monitor these patients post-procedure and report back to the surgeon or attending
if there are any significant status changes. Pharmacists also have a role in recognizing the
medications which can cause urinary retention and coordinating efforts with the prescribing
clinician.[2][33][138] Unfortunately, despite optimal treatment, the recurrence of urinary
retention is relatively common. Open communication between all team members is necessary for
optimal outcomes, including keeping accurate and updated patient records so that all
interprofessional team members can access the same updated patient information. [Level 5]
Review Questions
Access free multiple choice questions on this topic.
Comment on this article.
References
1. Juma S. Urinary retention in women. Curr Opin Urol. 2014 Jul;24(4):375-9. [PubMed:
24901515]
2. Justo D, Schwartz N, Dvorkin E, Gringauz I, Groutz A. Asymptomatic urinary retention in
elderly women upon admission to the Internal Medicine department: A prospective study.
Neurourol Urodyn. 2017 Mar;36(3):794-797. [PubMed: 27176656]
3. Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. AUA White Paper on
Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and
Outcome End Points. J Urol. 2017 Jul;198(1):153-160. [PubMed: 28163030]
4. Cheung F, Sandhu JS. Voiding Dysfunction After Non-urologic Pelvic Surgery. Curr Urol
Rep. 2018 Aug 06;19(9):75. [PubMed: 30083849]
5. He H, Tang C, Yi X, Zhou W. Herpes zoster-induced acute urinary retention: Two cases and
literature review. Niger J Clin Pract. 2018 Apr;21(4):534-537. [PubMed: 29607871]
6. Sungur M, Baykam M, Calışkan S, Lokman U. Urethral calculi: A rare cause of acute urinary
retention in women. Turk J Emerg Med. 2018 Dec;18(4):170-171. [PMC free article:
PMC6261834] [PubMed: 30533562]
7. Prattley S, Voss J, Cheung S, Geraghty R, Jones P, Somani BK. Ureteroscopy and stone
treatment in the elderly (≥70 years): prospective outcomes over 5- years with a review of
literature. Int Braz J Urol. 2018 Jul-Aug;44(4):750-757. [PMC free article: PMC6092651]
[PubMed: 29522293]
8. Malik RD, Cohn JA, Bales GT. Urinary retention in elderly women: diagnosis &
management. Curr Urol Rep. 2014 Nov;15(11):454. [PubMed: 25234188]
9. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van
Kerrebroeck P, Wein AJ. Detrusor underactivity and the underactive bladder: a new clinical
entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis.
Eur Urol. 2014 Feb;65(2):389-98. [PubMed: 24184024]
10. Abarbanel J, Marcus EL. Impaired detrusor contractility in community-dwelling elderly
presenting with lower urinary tract symptoms. Urology. 2007 Mar;69(3):436-40. [PubMed:
17382138]
11. Pfisterer MH, Griffiths DJ, Schaefer W, Resnick NM. The effect of age on lower urinary
tract function: a study in women. J Am Geriatr Soc. 2006 Mar;54(3):405-12. [PubMed:
16551306]
12. Hald T, Horn T. The human urinary bladder in ageing. Br J Urol. 1998 Dec;82 Suppl 1:59-
64. [PubMed: 9883263]
13. Collas DM, Malone-Lee JG. Age-associated changes in detrusor sensory function in women
with lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(1):24-9.
[PubMed: 8798083]
14. Griffiths D, Tadic SD, Schaefer W, Resnick NM. Cerebral control of the bladder in normal
and urge-incontinent women. Neuroimage. 2007 Aug 01;37(1):1-7. [PMC free article:
PMC2075467] [PubMed: 17574871]
15. Lukacz ES, DuHamel E, Menefee SA, Luber KM. Elevated postvoid residual in women
with pelvic floor disorders: prevalence and associated risk factors. Int Urogynecol J Pelvic
Floor Dysfunct. 2007 Apr;18(4):397-400. [PubMed: 16804634]
16. Lowenstein L, Anderson C, Kenton K, Dooley Y, Brubaker L. Obstructive voiding
symptoms are not predictive of elevated postvoid residual urine volumes. Int Urogynecol J
Pelvic Floor Dysfunct. 2008 Jun;19(6):801-4. [PubMed: 18074067]
17. Andrada AO, De Vicente JM, Cidre MA. Pelvic plexus compression due to a uterine leiomyoma
in a woman with acute urinary retention: a new hypothesis. Int Urogynecol J. 2014
Mar;25(3):429-31. [PubMed: 23857064]
18. Gheiler EL, Tefilli MV, Tiguert R, de Oliveira JG, Pontes JE, Wood DP. Management of
primary urethral cancer. Urology. 1998 Sep;52(3):487-93. [PubMed: 9730466]
19. Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: definition and
characteristics. Neurourol Urodyn. 2000;19(3):213-20. [PubMed: 10797578]
20. Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ. Effects of diabetes on female voiding
behavior. J Urol. 2004 Sep;172(3):989-92. [PubMed: 15311019]
21. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to
management. Pharmacol Ther. 2008 Oct;120(1):1-34. [PMC free article: PMC4007052]
[PubMed: 18616962]
22. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J
Urol. 1995 Feb;153(2):342-4. [PubMed: 7815578]
23. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we
now and where to go? J Diabetes Investig. 2011 Jan 24;2(1):18-32. [PMC free article:
PMC4008011] [PubMed: 24843457]
24. Fowler CJ, Christmas TJ, Chapple CR, Parkhouse HF, Kirby RS, Jacobs HS. Abnormal
electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic
ovaries: a new syndrome? BMJ. 1988 Dec 03;297(6661):1436-8. [PMC free article:
PMC1835186] [PubMed: 3147005]
25. Szymański JK, Słabuszewska-Jóźwiak A, Jakiel G. Fowler's Syndrome-The Cause of
Urinary Retention in Young Women, Often Forgotten, but Significant and Challenging to
Treat. Int J Environ Res Public Health. 2021 Mar 23;18(6) [PMC free article:
PMC8005021] [PubMed: 33806865]
26. Swinn MJ, Fowler CJ. Isolated urinary retention in young women, or Fowler's syndrome.
Clin Auton Res. 2001 Oct;11(5):309-11. [PubMed: 11758797]
27. Kavia RB, Datta SN, Dasgupta R, Elneil S, Fowler CJ. Urinary retention in women: its
causes and management. BJU Int. 2006 Feb;97(2):281-7. [PubMed: 16430630]
28. Osman NI, Chapple CR. Fowler's syndrome--a cause of unexplained urinary retention in
young women? Nat Rev Urol. 2014 Feb;11(2):87-98. [PubMed: 24323131]
29. Mevcha A, Drake MJ. Etiology and management of urinary retention in women. Indian J
Urol. 2010 Apr;26(2):230-5. [PMC free article: PMC2938548] [PubMed: 20877602]
30. Podnar S, Barbic M. Non-neurogenic urinary retention (Fowler's syndrome) in two sisters.
Neurourol Urodyn. 2006;25(7):739-41; discussion 742-3. [PubMed: 16819763]
31. Swartzberg K, Adam A, Motara F, Laher AE. A Case of Female Acute Urinary Retention
Presenting to the ED. Case Rep Emerg Med. 2017;2017:4598314. [PMC free article:
PMC5576393] [PubMed: 28900548]
32. Klarskov P, Andersen JT, Asmussen CF, Brenøe J, Jensen SK, Jensen IL, Lund P, Schultz
A, Vedel T. Acute urinary retention in women: a prospective study of 18 consecutive cases.
Scand J Urol Nephrol. 1987;21(1):29-31. [PubMed: 3589520]
33. Marshall JR, Haber J, Josephson EB. An evidence-based approach to emergency
department management of acute urinary retention. Emerg Med Pract. 2014 Jan;16(1):1-20;
quiz 21. [PubMed: 24804332]
34. Grosshans C, Passadori Y, Peter B. Urinary retention in the elderly: a study of 100
hospitalized patients. J Am Geriatr Soc. 1993 Jun;41(6):633-8. [PubMed: 8505461]
35. El-Azab AS, Siegel SW. Sacral neuromodulation for female pelvic floor disorders. Arab J
Urol. 2019 Mar;17(1):14-22. [PMC free article: PMC6583747] [PubMed: 31258941]
36. Anglim BC, Tomlinson G, Paquette J, McDermott CD. A risk calculator for postoperative
urinary retention (POUR) following vaginal pelvic floor surgery: multivariable prediction
modelling. BJOG. 2022 Dec;129(13):2203-2213. [PubMed: 35596931]

37. Yoshida A, Yoshida M, Kawajiri M, Takeishi Y, Nakamura Y, Yoshizawa T. Prevalence of
urinary retention after vaginal delivery: a systematic review and meta- analysis. Int
Urogynecol J. 2022 Dec;33(12):3307-3323. [PubMed: 35689691]
38. Pettersson K, Ajne J, Yousaf K, Sturm D, Westgren M, Ajne G. Traction force during
vacuum extraction: a prospective observational study. BJOG. 2015 Dec;122(13):1809-16.
[PubMed: 25558833]
39. Gupta A, Pampapati V, Khare C, Murugesan R, Nayak D, Keepanasseril A. Postpartum
urinary retention in women undergoing instrumental delivery: A cross-sectional analytical
study. Acta Obstet Gynecol Scand. 2021 Jan;100(1):41-47. [PubMed: 32652531]
40. Mohr S, Raio L, Gobrecht-Keller U, Imboden S, Mueller MD, Kuhn A. Postpartum urinary
retention: what are the sequelae? A long-term study and review of the literature. Int
Urogynecol J. 2022 Jun;33(6):1601-1608. [PMC free article: PMC9206615] [PubMed:
35129645]
41. Lethaby A, Mukhopadhyay A, Naik R. Total versus subtotal hysterectomy for benign
gynaecological conditions. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004993.
[PubMed: 22513925]
42. Tseng CJ, Shen HP, Lin YH, Lee CY, Wei-Cheng Chiu W. A prospective study of nerve-
sparing radical hysterectomy for uterine cervical carcinoma in Taiwan. Taiwan J Obstet
Gynecol. 2012 Mar;51(1):55-9. [PubMed: 22482969]
43. Ceccaroni M, Roviglione G, Spagnolo E, Casadio P, Clarizia R, Peiretti M, Bruni F, Peters
I, Aletti G. Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy:
a multicenter comparative study. Anticancer Res. 2012 Feb;32(2):581-8. [PubMed:
22287748]
44. Ibeanu OA, Chesson RR, Echols KT, Nieves M, Busangu F, Nolan TE. Urinary tract injury
during hysterectomy based on universal cystoscopy. Obstet Gynecol. 2009 Jan;113(1):6-10.
[PubMed: 19104353]
45. Brubaker L. Is routine cystoscopy an essential intraoperative test at hysterectomy? Obstet
Gynecol. 2009 Jan;113(1):2-3. [PubMed: 19104351]
46. Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE, Chai TC, Zyczynski
H, Diokno AC, Tennstedt S, Nager C, Lloyd LK, FitzGerald M, Lemack GE, Johnson HW,
Leng W, Mallett V, Stoddard AM, Menefee S, Varner RE, Kenton K, Moalli P, Sirls L,
Dandreo KJ, Kusek JW, Nyberg LM, Steers W., Urinary Incontinence Treatment Network.
Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J
Med. 2007 May 24;356(21):2143-55. [PubMed: 17517855]
47. Tincello DG, Botha T, Grier D, Jones P, Subramanian D, Urquhart C, Kirkemo A,
Khandwala S., TVT Worldwide Registry Investigators. The TVT Worldwide Observational
Registry for Long-Term Data: safety and efficacy of suburethral sling insertion approaches
for stress urinary incontinence in women. J Urol. 2011 Dec;186(6):2310-5. [PubMed:
22014817]
48. Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo KJ, Lloyd KL, Lowder JL, Sirls LT,
Lemack GE, Arisco AM, Xu Y, Kusek JW., Urinary Incontinence Treatment Network.
Adverse events over two years after retropubic or transobturator midurethral sling surgery:
findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol. 2011
Nov;205(5):498.e1-6. [PMC free article: PMC3205289] [PubMed: 21925636]
49. Anim-Somuah M, Smyth RM, Cyna AM, Cuthbert A. Epidural versus non-epidural or no
analgesia for pain management in labour. Cochrane Database Syst Rev. 2018 May
21;5(5):CD000331. [PMC free article: PMC6494646] [PubMed: 29781504]
50. Valentini FA, Marti BG, Robain G. Do urodynamics provide a better understanding of
voiding disorders in women over 80? Prog Urol. 2018 Mar;28(4):230-235. [PubMed:
29307483]
51. Schwertner-Tiepelmann N, Hagedorn-Wiesner A, Erschig C, Beilecke K, Schwab F, Tunn
R. Clinical relevance of neurological evaluation in patients suffering urinary retention in the
absence of subvesical obstruction. Arch Gynecol Obstet. 2017 Nov;296(5):1017-1025.
[PubMed: 28900705]
52. Verzotti G, Fenner V, Wirth G, Iselin CE. [Acute urinary retention: a mechanical or
functional emergency]. Rev Med Suisse. 2016 Nov 30;12(541):2060-2063. [PubMed:
28700149]
53. Dwyer PL, Desmedt E. Impaired bladder emptying in women. Aust N Z J Obstet Gynaecol.
1994 Feb;34(1):73-8. [PubMed: 8053880]
54. Brock C, Olesen SS, Olesen AE, Frøkjaer JB, Andresen T, Drewes AM. Opioid-induced
bowel dysfunction: pathophysiology and management. Drugs. 2012 Oct 01;72(14):1847-65.
[PubMed: 22950533]
55. Yates A. Urinary continence care for older people in the acute setting. Br J Nurs. 2017 May
11;26(9):S28-S30. [PubMed: 28493778]
56. Zahid AS, Mubashir A, Mirza SA, Naqvi IH, Talib A. Systemic Lupus Erythematosus
Presenting as Longitudinally Extensive Transverse Myelitis and Nephritis: A Case Report.
Cureus. 2018 Apr 01;10(4):e2402. [PMC free article: PMC5984254] [PubMed: 29872583]
57. Manjunath AS, Hofer MD. Urologic Emergencies. Med Clin North Am. 2018
Mar;102(2):373-385. [PubMed: 29406065]
58. Ugare UG, Bassey IA, Udosen EJ, Essiet A, Bassey OO. Management of lower urinary
retention in a limited resource setting. Ethiop J Health Sci. 2014 Oct;24(4):329-36. [PMC
free article: PMC4248032] [PubMed: 25489197]
59. Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic and
perioperative considerations. Anesthesiology. 2009 May;110(5):1139-57. [PubMed:
19352147]
60. Hansen BS, Søreide E, Warland AM, Nilsen OB. Risk factors of post-operative urinary
retention in hospitalised patients. Acta Anaesthesiol Scand. 2011 May;55(5):545-8.
[PubMed: 21418152]
61. Dreijer B, Møller MH, Bartholdy J. Post-operative urinary retention in a general surgical
population. Eur J Anaesthesiol. 2011 Mar;28(3):190-4. [PubMed: 21206278]
62. Bosch JL, Norton P, Jones JS. Should we screen for and treat lower urinary tract
dysfunction after major pelvic surgery? ICI-RS 2011. Neurourol Urodyn. 2012
Mar;31(3):327-9. [PubMed: 22415890]
63. Jeon S, Yoo EH. Predictive value of obstructive voiding symptoms and objective bladder
emptying tests for urinary retention. J Obstet Gynaecol. 2012 Nov;32(8):770-2. [PubMed:
23075353]
64. Chang SJ, Yang SS, Chiang IN. Large voided volume suggestive of abnormal uroflow
pattern and elevated post-void residual urine. Neurourol Urodyn. 2011 Jan;30(1):58-61.
[PubMed: 20623612]
65. Gehrich A, Stany MP, Fischer JR, Buller J, Zahn CM. Establishing a mean postvoid residual
volume in asymptomatic perimenopausal and postmenopausal women. Obstet Gynecol.
2007 Oct;110(4):827-32. [PubMed: 17906016]
66. Haylen BT, Lee J, Logan V, Husselbee S, Zhou J, Law M. Immediate postvoid residual
volumes in women with symptoms of pelvic floor dysfunction. Obstet Gynecol. 2008
Jun;111(6):1305-12. [PubMed: 18515513]
67. Özveren B, Keskin S. Presentation and prognosis of female acute urinary retention:
Analysis of an unusual clinical condition in outpatients. Urol Ann. 2016 Oct-Dec;8(4):444-
448. [PMC free article: PMC5100150] [PubMed: 28057989]
68. Daurat A, Choquet O, Bringuier S, Charbit J, Egan M, Capdevila X. Diagnosis of
Postoperative Urinary Retention Using a Simplified Ultrasound Bladder Measurement.

Anesth Analg. 2015 May;120(5):1033-1038. [PubMed: 25642660]
69. Yao M, Simoes A. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 8,
2022. Urodynamic Testing and Interpretation. [PubMed: 32965981]
70. Defreitas GA, Zimmern PE, Lemack GE, Shariat SF. Refining diagnosis of anatomic female
bladder outlet obstruction: comparison of pressure-flow study parameters in clinically
obstructed women with those of normal controls. Urology. 2004 Oct;64(4):675-9;
discussion 679-81. [PubMed: 15491697]
71. Mytilekas KV, Oeconomou A, Sokolakis I, Kalaitzi M, Mouzakitis G, Nakopoulou E,
Apostolidis A. Defining Voiding Dysfunction in Women: Bladder Outflow Obstruction
Versus Detrusor Underactivity. Int Neurourol J. 2021 Sep;25(3):244-251. [PMC free article:
PMC8497729] [PubMed: 33957716]
72. Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary
tract symptomatology. Neurourol Urodyn. 2000;19(5):553-64. [PubMed: 11002298]
73. Pang KH, Campi R, Arlandis S, Bo K, Chapple CR, Costantini E, Farag F, Groen J,
Karavitakis M, Lapitan MC, Manso M, Monagas Arteaga S, Nambiar AK, Nic An Ríogh
AU, O'Connor EM, Osman NI, Peyronnet B, Phé V, Sakalis VI, Sihra N, Tzelves L, van der
Vaart H, Yuan Y, Omar MI, Harding CK. Diagnostic Tests for Female Bladder Outlet
Obstruction: A Systematic Review from the European Association of Urology Non-
neurogenic Female LUTS Guidelines Panel. Eur Urol Focus. 2022 Jul;8(4):1015-1030.
[PubMed: 34538750]
74. Deffieux X, Thubert T, Amarenco G. [Contribution of investigations to the diagnosis of
bladder outlet obstruction in women]. Prog Urol. 2012 Oct;22(11):628-35. [PubMed:
22999087]
75. Brucker BM, Fong E, Shah S, Kelly C, Rosenblum N, Nitti VW. Urodynamic differences
between dysfunctional voiding and primary bladder neck obstruction in women. Urology.
2012 Jul;80(1):55-60. [PubMed: 22748864]
76. Nitti VW, Tu LM, Gitlin J. Diagnosing bladder outlet obstruction in women. J Urol. 1999
May;161(5):1535-40. [PubMed: 10210391]
77. Leslie SW, Sajjad H, Sharma S. StatPearls [Internet]. StatPearls Publishing; Treasure Island
(FL): Nov 28, 2022. Postobstructive Diuresis. [PubMed: 29083564]
78. Takahashi R, Kimoto Y, Maki T, Eto M. Postinjury Bladder Overdistension Deteriorates the
Lower Urinary Tract's Storage Function in Patients with Spinal Cord Injury. Urol Int.
2020;104(7-8):604-609. [PubMed: 32594087]
79. Saito M, Miyagawa I. Bladder dysfunction after acute urinary retention in rats. J Urol. 2001
May;165(5):1745-7. [PubMed: 11342968]
80. Zhao Y, Levin SS, Wein AJ, Levin RM. Correlation of ischemia/reperfusion or partial outlet
obstruction-induced spectrin proteolysis by calpain with contractile dysfunction in rabbit
bladder. Urology. 1997 Feb;49(2):293-300. [PubMed: 9037302]
81. Shin JH, Chun KS, Na YG, Song KH, Kim SI, Lim JS, Kim GH. Allopurinol Protects
against Ischemia/Reperfusion-Induced Injury in Rat Urinary Bladders. Oxid Med Cell
Longev. 2015;2015:906787. [PMC free article: PMC4600567] [PubMed: 26491537]
82. Collado A, Batista E, Gelabert-Más A, Corominas JM, Arañó P, Villavicencio H. Detrusor
quantitative morphometry in obstructed males and controls. J Urol. 2006 Dec;176(6 Pt
1):2722-8. [PubMed: 17085203]
83. Patel MI, Watts W, Grant A. The optimal form of urinary drainage after acute retention of
urine. BJU Int. 2001 Jul;88(1):26-9. [PubMed: 11446840]
84. Smith NK, Morrant JD. Post-operative urinary retention in women: management by
intermittent catheterization. Age Ageing. 1990 Sep;19(5):337-40. [PubMed: 2251968]
85. Phillips B, Holzmer S, Turco L, Mirzaie M, Mause E, Mause A, Person A, Leslie SW,
Cornell DL, Wagner M, Bertellotti R, Asensio JA. Trauma to the bladder and ureter: a
review of diagnosis, management, and prognosis. Eur J Trauma Emerg Surg. 2017
Dec;43(6):763-773. [PubMed: 28730297]
86. Tullington JE, Blecker N. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL):
Mar 1, 2023. Lower Genitourinary Trauma. [PubMed: 32491459]
87. Kang L, Geube A. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May
23, 2022. Bladder Trauma. [PubMed: 32491798]
88. Morey AF, Broghammer JA, Hollowell CMP, McKibben MJ, Souter L. Urotrauma
Guideline 2020: AUA Guideline. J Urol. 2021 Jan;205(1):30-35. [PubMed: 33053308]
89. Michelson JD, Lotke PA, Steinberg ME. Urinary-bladder management after total joint-
replacement surgery. N Engl J Med. 1988 Aug 11;319(6):321-6. [PubMed: 3393193]
90. Chapple CR, Osman NI, Birder L, van Koeveringe GA, Oelke M, Nitti VW, Drake MJ,
Yamaguchi O, Abrams P, Smith PP. The underactive bladder: a new clinical concept? Eur
Urol. 2015 Sep;68(3):351-3. [PubMed: 25770481]
91. Chapman GC, Sheyn D, Petrikovets A, Mahajan ST, El-Nashar S, Pollard R, Mangel JM.
Tamsulosin to Prevent Postoperative Urinary Retention After Female Pelvic Reconstructive
Surgery. Female Pelvic Med Reconstr Surg. 2020 Nov;26(11):682-687. [PubMed:
30418263]
92. Minardi D, d'Anzeo G, Parri G, Polito M, Piergallina M, El Asmar Z, Marchetti M,
Muzzonigro G. The role of uroflowmetry biofeedback and biofeedback training of the
pelvic floor muscles in the treatment of recurrent urinary tract infections in women with
dysfunctional voiding: a randomized controlled prospective study. Urology. 2010
Jun;75(6):1299-304. [PubMed: 20303577]
93. Lazarou G, Scotti RJ, Mikhail MS, Zhou HS, Powers K. Pessary reduction and
postoperative cure of retention in women with anterior vaginal wall prolapse. Int
Urogynecol J Pelvic Floor Dysfunct. 2004 May-Jun;15(3):175-8. [PubMed: 15167996]
94. Fitzgerald MP, Kulkarni N, Fenner D. Postoperative resolution of urinary retention in
patients with advanced pelvic organ prolapse. Am J Obstet Gynecol. 2000
Dec;183(6):1361-3; discussion 1363-4. [PubMed: 11120497]
95. Bergman A, Karram M, Bhatia NN. Urethral syndrome. A comparison of different
treatment modalities. J Reprod Med. 1989 Feb;34(2):157-60. [PubMed: 2926732]
96. Carson CC, Segura JW, Osborne DM. Evaluation and treatment of the female urethral
syndrome. J Urol. 1980 Nov;124(5):609-10. [PubMed: 7452783]
97. Rutherford AJ, Hinshaw K, Essenhigh DM, Neal DE. Urethral dilatation compared with
cystoscopy alone in the treatment of women with recurrent frequency and dysuria. Br J
Urol. 1988 Jun;61(6):500-4. [PubMed: 3401660]
98. Amundsen CL, Flynn BJ, Webster GD. Urethral erosion after synthetic and nonsynthetic
pubovaginal slings: differences in management and continence outcome. J Urol. 2003
Jul;170(1):134-7; discussion 137. [PubMed: 12796665]
99. Sergouniotis F, Jarlshammar B, Larsson PG. Urethral complications after tension-free
vaginal tape procedures: A surgical management case series. World J Nephrol. 2015 Jul
06;4(3):396-405. [PMC free article: PMC4491931] [PubMed: 26167464]
100. Zhang P, Wu ZJ, Xu L, Yang Y, Zhang N, Zhang XD. Bladder neck incision for female
bladder neck obstruction: long-term outcomes. Urology. 2014 Apr;83(4):762-6. [PubMed:
24680443]
101. Kalra S, Bokka SH, Dorairajan LN, Manikandan R, Sreerag KS, Jagannath A. Clinical and
videourodynamic study characteristics in female primary bladder neck obstruction and
outcomes of bladder neck resection: A tertiary care center experience in India. Urol Ann.
2022 Apr-Jun;14(2):125-131. [PMC free article: PMC9197009] [PubMed: 35711475]
102. Barrett DM. The effect of oral bethanechol chloride on voiding in female patients with
excessive residual urine: a randomized double-blind study. J Urol. 1981 Nov;126(5):640-2.

[PubMed: 6117662]
103. Hindley RG, Brierly RD, Thomas PJ. Prostaglandin E2 and bethanechol in combination
for treating detrusor underactivity. BJU Int. 2004 Jan;93(1):89-92. [PubMed: 14678375]
104. Barendrecht MM, Oelke M, Laguna MP, Michel MC. Is the use of parasympathomimetics
for treating an underactive urinary bladder evidence-based? BJU Int. 2007 Apr;99(4):749-
52. [PubMed: 17233798]
105. Lee KS, Han DH, Lee YS, Choo MS, Yoo TK, Park HJ, Yoon H, Jeong H, Lee SJ, Kim H,
Park WH. Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding
dysfunction in females: a 8-week prospective study. J Korean Med Sci. 2010
Jan;25(1):117-22. [PMC free article: PMC2800025] [PubMed: 20052356]
106. Kessler TM, Studer UE, Burkhard FC. The effect of terazosin on functional bladder outlet
obstruction in women: a pilot study. J Urol. 2006 Oct;176(4 Pt 1):1487-92. [PubMed:
16952666]
107. Low BY, Liong ML, Yuen KH, Chee C, Leong WS, Chong WL, Khan NA, Cheah PY,
Liong KK. Terazosin therapy for patients with female lower urinary tract symptoms: a
randomized, double-blind, placebo controlled trial. J Urol. 2008 Apr;179(4):1461-9.
[PubMed: 18295277]
108. Boyd K, Hilas O. α-adrenergic blockers for the treatment of lower-urinary-tract symptoms
and dysfunction in women. Ann Pharmacother. 2014 Jun;48(6):711-22. [PubMed:
24615630]
109. Meyer LE, Brown JN. Tamsulosin for voiding dysfunction in women. Int Urol Nephrol.
2012 Dec;44(6):1649-56. [PubMed: 22983886]
110. Maiti K, Jaiswal A, Pal DK. A comparative study of alpha-1a blockers (tamsulosin) versus
estrogens in the treatment of lower urinary tract symptoms in perimenopausal females.
Indian J Pharmacol. 2020 Jan-Feb;52(1):6-9. [PMC free article: PMC7074429] [PubMed:
32201440]
111. Chapman GC, Sheyn D, Slopnick EA, Roberts K, El-Nashar SA, Henderson JW, Mangel J,
Hijaz AK, Pollard RR, Mahajan ST. Tamsulosin vs placebo to prevent postoperative
urinary retention following female pelvic reconstructive surgery: a multicenter randomized
controlled trial. Am J Obstet Gynecol. 2021 Sep;225(3):274.e1-274.e11. [PubMed:
33894146]
112. Dasgupta R, Wiseman OJ, Kitchen N, Fowler CJ. Long-term results of sacral
neuromodulation for women with urinary retention. BJU Int. 2004 Aug;94(3):335-7.
[PubMed: 15291863]
113. Feloney MP, Stauss K, Leslie SW. StatPearls [Internet]. StatPearls Publishing; Treasure
Island (FL): Nov 28, 2022. Sacral Neuromodulation. [PubMed: 33620828]
114. Mehmood S, Altaweel WM. Long-term outcome of sacral neuromodulation in patients
with idiopathic nonobstructive urinary retention: Single-center experience. Urol Ann. 2017
Jul-Sep;9(3):244-248. [PMC free article: PMC5532891] [PubMed: 28794590]
115. High RA, Winkelman W, Panza J, Sanderson DJ, Yuen H, Halder GE, Shaver C, Bird ET,
Rogers RG, Danford JM. Sacral neuromodulation for symptomatic chronic urinary
retention in females: do age and comorbidities make a difference? Int Urogynecol J. 2021
Oct;32(10):2703-2715. [PubMed: 32902761]
116. DasGupta R, Fowler CJ. Urodynamic study of women in urinary retention treated with
sacral neuromodulation. J Urol. 2004 Mar;171(3):1161-4. [PubMed: 14767292]
117. Minardi D, Muzzonigro G. Sacral neuromodulation in patients with multiple sclerosis.
World J Urol. 2012 Feb;30(1):123-8. [PubMed: 21400258]
118. Albabtain M, Chughtai B, Cho A, Elterman D. Review of the rechargeable sacral
neuromodulation system to treat refractory overactive bladder. Ther Deliv. 2021
May;12(5):353-362. [PubMed: 33821666]

119. Hijaz A, Vasavada SP, Daneshgari F, Frinjari H, Goldman H, Rackley R. Complications
and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution
experience. Urology. 2006 Sep;68(3):533-7. [PubMed: 16979724]
120. Blandon RE, Gebhart JB, Lightner DJ, Klingele CJ. Re-operation rates after permanent
sacral nerve stimulation for refractory voiding dysfunction in women. BJU Int. 2008
May;101(9):1119-23. [PubMed: 18190624]
121. Al-zahrani AA, Elzayat EA, Gajewski JB. Long-term outcome and surgical interventions
after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience
at 1 center. J Urol. 2011 Mar;185(3):981-6. [PubMed: 21247597]
122. Marinkovic SP. Improving clinical outcomes with lower motor voltage (≤3 V) during stage
1 sacral neuromodulation for interstitial cystitis or bladder pain syndrome. Neurourol
Urodyn. 2019 Nov;38(8):2233-2241. [PubMed: 31512775]
123. Fowler CJ, Betts CD, Christmas TJ, Swash M, Fowler CG. Botulinum toxin in the
treatment of chronic urinary retention in women. Br J Urol. 1992 Oct;70(4):387-9.
[PubMed: 1450846]
124. Kao YL, Huang KH, Kuo HC, Ou YC. The Therapeutic Effects and Pathophysiology of
Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.
Toxins (Basel). 2019 Dec 13;11(12) [PMC free article: PMC6950422] [PubMed:
31847090]
125. Lee YK, Kuo HC. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter
Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter
Dysfunctions. Toxins (Basel). 2019 Aug 23;11(9) [PMC free article: PMC6784014]
[PubMed: 31450851]
126. Coolen RL, Groen J, Scheepe JR, Blok BFM. Transcutaneous Electrical Nerve Stimulation
and Percutaneous Tibial Nerve Stimulation to Treat Idiopathic Nonobstructive Urinary
Retention: A Systematic Review. Eur Urol Focus. 2021 Sep;7(5):1184-1194. [PubMed:
33268327]
127. Chern BZH, Rajaraman S, Verma G, Heng KWJ. Unusual case of acute urinary retention
in a young female. BMJ Case Rep. 2017 Oct 04;2017 [PMC free article: PMC5652365]
[PubMed: 28978599]
128. Cui G, Zhang Y, Liu Z, Li X, Sha M. Effect of Predictive Nursing Combined with Early
Drinking Water Therapy on Patients with Urinary Retention after Vaginal Delivery.
Comput Math Methods Med. 2022;2022:4204762. [PMC free article: PMC9262503]
[PubMed: 35813411]
129. Chen TY, Ponsot Y, Carmel M, Bouffard N, Kennelly MJ, Tu LM. Multi-centre study of
intraurethral valve-pump catheter in women with a hypocontractile or acontractile bladder.
Eur Urol. 2005 Oct;48(4):628-33. [PubMed: 15964124]
130. Hartigan SM, Dmochowski RR. The inFlow intraurethral valve-pump for women with
detrusor underactivity: A summary of peer-reviewed literature. J Spinal Cord Med. 2022
Jul;45(4):489-497. [PMC free article: PMC9246140] [PubMed: 33054612]
131. Schurch B, Suter S, Dubs M. Intraurethral sphincter prosthesis to treat hyporeflexic
bladders in women: does it work? BJU Int. 1999 Nov;84(7):789-94. [PubMed: 10532973]
132. Declemy A, Chesnel C, Charlanes A, Le Breton F, Ismael SS, Amarenco G. Specificity of
Lower Urinary Tract Symptoms in Neuromyelitis Optica in Comparison With Multiple
Sclerosis Patients. Int Neurourol J. 2018 Sep;22(3):185-191. [PMC free article:
PMC6177731] [PubMed: 30286581]
133. Čadková I, Huvar I. [Vaginal reconstruction for the remedy of pelvic organ prolapse: the
effect, influence on urinary and sexual function and quality of life in two-years follow-up
Part II - Urinary tract: function and complications]. Ceska Gynekol. 2018
Summer;83(2):94-102. [PubMed: 29869506]

134. Scott AJ, Mason SE, Langdon AJ, Patel B, Mayer E, Moorthy K, Purkayastha S.
Prospective Risk Factor Analysis for the Development of Post-operative Urinary Retention
Following Ambulatory General Surgery. World J Surg. 2018 Dec;42(12):3874-3879.
[PMC free article: PMC6244976] [PubMed: 29947990]
135. Nyman MA, Schwenk NM, Silverstein MD. Management of urinary retention: rapid
versus gradual decompression and risk of complications. Mayo Clin Proc. 1997
Oct;72(10):951-6. [PubMed: 9379700]
136. Chen SF, Jhang JF, Jiang YH, Kuo HC. Treatment outcomes of detrusor underactivity in
women based on clinical and videourodynamic characteristics. Int Urol Nephrol. 2022
Jun;54(6):1215-1223. [PubMed: 35294677]
137. Khan S, Madhok M. Pubescent Girl With Urinary Retention. J Emerg Med. 2022
Feb;62(2):260-263. [PubMed: 35031168]
138. Marinkovic SP, Ford JC. Improving clinical outcomes for women with overactive bladder
or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during
Stage 1 sacral neuromodulation. BJU Int. 2018 Sep;122(3):472-479. [PubMed: 29637712]
Disclosure: Stephen Leslie declares no relevant financial relationships with ineligible companies.
Disclosure: Prashanth Rawla declares no relevant financial relationships with ineligible companies.
Disclosure: Joseph Dougherty declares no relevant financial relationships with ineligible companies.
Copyright © 2023, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
(CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work,
provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article,
provided that you credit the author and journal.
Bookshelf ID: NBK538497 PMID: 30860732

Female Urinary Retention - StatPearls - NCBI Bookshelf

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Female Urinary Retention - StatPearls - NCBI Bookshelf

Uploaded by

Copyright:

Available Formats

Female Urinary Retention - StatPearls - NCBI Bookshelf 03/11/23, 9:25 AM

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.

Author Information and Affiliations

Continuing Education Activity

Identify the causes of urinary retention in females.

Review risk factors for urinary retention in females.

Describe treatment options for urinary retention in females.

Explain the importance of improving coordination amongst the interprofessional team to

Access free multiple choice questions on this topic.

Complete (full retention) or partial (high post-void residuals)

Mechanism (obstructive or non-obstructive)

Bladder pressure: high or low

A number of etiologies exist for this condition.[4][5][6][7][8][9] Common specific causes

Anesthesia (general or regional)

Bladder neck stenosis

Brain tumor, infection, trauma, or stroke

Cauda equina syndrome

Cystotomy not recognized during surgery

Detrusor sphincter dyssynergia

Heavy metal poisoning

Iatrogenic nerve injury during pelvic surgery

Joint replacement surgery

Neurologic injury during surgery

Pelvic injury, trauma, or malignancy

Pelvic organ prolapse

Pessary: poorly fitting or out of position

Pharmacological from long-term use of antihistamines, anticholinergics, overactive

Spinal cord injury or infection

Surgery, especially incontinence procedures such as pubovaginal slings

Urethral diverticula or thrombosed caruncle

Urethral injury or scarring

Urethral swelling from infection

Vaginal childbirth; especially if instruments were required

Vaginal lichen planus

Detrusor underactivity is defined as a contraction of reduced strength and/or duration, which

Fowler's syndrome is characterized by the following characteristics:[25][28]

Younger women in 2nd and 3rd decades of life

Not associated with pelvic surgery or childbirth

Increased bladder capacity

Decreased bladder sensation

Markedly reduced bladder contractions and detrusor voiding pressures

Increased sphincteric volume on transvaginal ultrasound

Intermittent catheterization is often painful, especially on withdrawal of the catheter

An unrecognized cystotomy as a complication of gynecologic surgery can also cause female

An unrecognized cystotomy during gynecologic surgery can initially appear as voiding

History and Physical

A post-void residual urine volume should be obtained, preferably within 10 to 15 minutes of

Age over 50 years

Administration of anticholinergic drugs during a surgical procedure

Creation of a cystotomy possibly unrecognized during GYN surgery

Duration of anesthesia of more than 2 hours

Higher IV fluid administration while under an anesthetic (>750 mL)

Joint replacement surgery

Neurological disease or injury

Pharmacological effects (anticholinergic, alpha agonists, etc.)

Preexisting voiding dysfunction or high post-void residual urine volumes

Previous episodes of urinary retention

Prior pelvic or incontinence surgery

Regional anesthesia (23% vs. 17% with a general anesthetic)

Surgery: radical hysterectomy - 20% rate of postop acute urinary retention

Risk factors for high-risk chronic urinary retention include:[3]

Recurrent or symptomatic UTIs